BIOASTER
Alexandre Moulin has a diverse work experience spanning several industries. Alexandre is currently serving as the Deputy CEO at BIOASTER since February 2017. Prior to this, Alexandre worked as the General Director at Fondation pour l'Université de Lyon from April 2014 to January 2017, and as the Development Director from December 2014 to December 2015. Alexandre also served as the Commissaire au redressement productif at Ministère de l'économie, des finances et de l'industrie from July 2012 to March 2014. Alexandre has held various leadership roles such as the Regional Deputy Director and Economic Development Manager at DRIRE Rhône-Alpes from January 2010 to March 2014, and the Regional Deputy Director and Economic Development Responsible at DRIRE from September 2006 to December 2009. Alexandre has also worked at DATAR as the Secretary General of CIALA and Mission Manager of Pôles de compétitivité from September 2004 to August 2006, as well as at DRIRE Aquitaine as the Deputy Director from September 2001 to August 2004. Alexandre has earlier experience as an IT and Process Control Manager at Arkema (Atofina, Elf Atochem, Total) from September 1999 to August 2000, and as an Intern at STMicrolectronics from September 1998 to August 1999.
Alexandre Moulin obtained a Master's degree from École Polytechnique from 1995 to 1998. Following this, from 1998 to 2001, Alexandre attended Mines Paris, but no specific degree or field of study information is provided.
BIOASTER
1 followers
BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures. BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries. More information on www.bioaster.org